C57BL/6J-Gnao1em2Katv/Cnrm

Status

Under development - register interest

EMMA IDEM:14988
International strain nameC57BL/6J-Gnao1em2Katv/Cnrm
Alternative nameB6.Gnao1 C215Y/Ugfm
Strain typeEndonuclease-mediated
Allele/Transgene symbolGnao1em2Katv,
Gene/Transgene symbolGnao1

Information from provider

ProviderFabrizio Thorel
Provider affiliationTransgenesis facility, University of Geneva
Genetic informationMutation: Gnao1 c.644G>A CRISPR/Cas9 gRNA: CCGTGACATCCTCAAAGCAG ssDNA:GGCCAGCGATCTGAACGCAAGAAGTGGATCCACTACTTTGAGGA TGTCACGGCCATCATCTTCTGTGTCGCACTCAGCGGCTATGACCAGG CRISPR technology details: Recombinant HiFi Cas9 Nuclease (cat. # 1081060 from IDT) mixed with nucleotides was directly injected in the embryos.
Phenotypic informationHomozygous:
The animals were found to exert no epilepsy-like behavior (no spontaneous seizures, visible movement difficulties were observed) or other abnormalities in housing conditions in either homozygous or heterozygous state. In certain behavioral experiments demonstrate weak-to-mild phenotypes of hyperkinesia. All the details can be found in associated publication (DOI: 10.1186/s40478-022-01312-z)

Heterozygous:
Certain mild differences were identified between homo- and heterozygous animals indicating certain aggravation of the phenotype in homozygous state. However, in the normal housing conditions homozygous animals are largely normal and good breeders.
Breeding historyGeneration of the mutant was performed on pure C57BL/6 background. F0 generation consisted of 1 heterozygous (male) and 5 homozygous (4 males, 1 female) animals. One homozygous male was chosen based on the best breeding performance and his sperm was the one deposited. At the time of the deposit we had produced F4 generation including both hetero- and homozygous animals.
References
  • Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.;Silachev Denis, Koval Alexey, Savitsky Mikhail, Padmasola Guru, Quairiaux Charles, Thorel Fabrizio, Katanaev Vladimir L, ;2022;Acta neuropathologica communications;10;9; 35090564
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreCNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

Literature references

  • Mouse models characterize GNAO1 encephalopathy as a neurodevelopmental disorder leading to motor anomalies: from a severe G203R to a milder C215Y mutation.;Silachev Denis, Koval Alexey, Savitsky Mikhail, Padmasola Guru, Quairiaux Charles, Thorel Fabrizio, Katanaev Vladimir L, ;2022;Acta neuropathologica communications;10;9; 35090564

Information on how we integrate external resources can be found here

Register interest

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable), as well as a CRISPR surcharge.

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).